Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Monoclonal"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1894
Tytuł:
Use of sulesomab in the diagnosis of brucellar spondylitis.
Autorzy:
Cascio A; Scuola di Specializzazione in Malattie Infettive, Dipartimento di Patologia Umana, Università di Messina, Messina, Italy. />Iaria C
Campennì A
Blandino A
Baldari S
Pokaż więcej
Źródło:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2004 Nov; Vol. 10 (11), pp. 1020-2.
Typ publikacji:
Evaluation Study; Journal Article
MeSH Terms:
Antibodies, Monoclonal*
Brucellosis/*diagnostic imaging
Spondylitis/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived ; Female ; Humans ; Leukocytes/diagnostic imaging ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Radionuclide Imaging ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Mimotope peptide modified pompon mum-like magnetic microparticles for precise recognition, capture and biotransformation analysis of rituximab in biological fluids
Autorzy:
Jiawen Yang
Aixuan Zhou
Minyi Li
Qiaoxian He
Jingwei Zhou
Jacques Crommen
Wentao Wang
Zhengjin Jiang
Qiqin Wang
Pokaż więcej
Temat:
Therapeutic monoclonal antibody
Mimotope peptide
Precise recognition
Peptide-based biomaterials
Biotransformation
Patient serum
Therapeutics. Pharmacology
RM1-950
Źródło:
Acta Pharmaceutica Sinica B, Vol 14, Iss 3, Pp 1317-1328 (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2211383523004124; https://doaj.org/toc/2211-3835
Dostęp URL:
https://doaj.org/article/462faa344e4940e5989c9b5d2eab206d  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Type III cryoglobulinemia associated with monoclonal gammopathy of uncertain significance and presenting with retiform purpura
Autorzy:
Michael J. Diaz, BS
Vivian Liu, MD
Mahtab Forouzandeh, MD
Kiran Motaparthi, MD
Pokaż więcej
Temat:
cryoglobulinemic vasculitis
mixed cryoglobulinemia
monoclonal gammopathy of uncertain significance
retiform purpura
type III
Dermatology
RL1-803
Źródło:
JAAD Case Reports, Vol 44, Iss , Pp 34-37 (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2352512623004186; https://doaj.org/toc/2352-5126
Dostęp URL:
https://doaj.org/article/54f7eb94e47c4aa7bbb7634ff7943d6a  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands.
Autorzy:
Essers BA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, Maastricht, The Netherlands. />Seferina SC
Tjan-Heijnen VC
Severens JL
Novák A
Pompen M
Oron UH
Joore MA
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Jun-Jul; Vol. 13 (4), pp. 375-80. Date of Electronic Publication: 2010 Jan 15.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Technology Transfer*
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*economics
Breast Neoplasms/*drug therapy
Cost-Benefit Analysis/*methods
Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Female ; Humans ; International Cooperation ; Models, Econometric ; Netherlands ; Quality-Adjusted Life Years ; Receptor, ErbB-2/metabolism ; Trastuzumab ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
An evaluation of the cost-effectiveness of rituximab in combination with chemotherapy for the first-line treatment of follicular non-Hodgkin's lymphoma in the UK.
Autorzy:
Ray JA; F. Hoffmann-La Roche, Ltd., Basel, Switzerland. />Carr E
Lewis G
Marcus R
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Jun-Jul; Vol. 13 (4), pp. 346-57. Date of Electronic Publication: 2010 Jan 08.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Direct Service Costs*
Drug Costs*
Antibodies, Monoclonal/*economics
Antineoplastic Combined Chemotherapy Protocols/*economics
Lymphoma, Follicular/*drug therapy
Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Murine-Derived ; Cost-Benefit Analysis ; Humans ; Markov Chains ; Models, Econometric ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic ; Rituximab ; Survival Analysis ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States.
Autorzy:
Krilov LR; Children's Medical Center, Winthrop University Hospital, Mineola, NY 11501, USA. />Palazzi DL
Fernandes AW
Klein RW
Mahadevia PJ
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Jan-Feb; Vol. 13 (1), pp. 77-86. Date of Electronic Publication: 2009 Aug 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cost of Illness*
Antibodies, Monoclonal/*therapeutic use
Antiviral Agents/*therapeutic use
Infant, Premature, Diseases/*economics
Insurance, Health/*economics
Respiratory Syncytial Virus Infections/*economics
Respiratory Syncytial Virus Infections/*prevention & control
Antibodies, Monoclonal/economics ; Antibodies, Monoclonal, Humanized ; Antiviral Agents/economics ; Chemoprevention/economics ; Cost-Benefit Analysis ; Cross-Sectional Studies ; Humans ; Immunosuppressive Agents/economics ; Immunosuppressive Agents/therapeutic use ; Infant, Newborn ; Infant, Premature ; Infant, Premature, Diseases/epidemiology ; Infant, Premature, Diseases/prevention & control ; Models, Econometric ; Palivizumab ; Prevalence ; Respiratory Syncytial Virus Infections/epidemiology ; Risk Factors ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
An economic evaluation of adjuvant trastuzumab therapy in HER2-positive early breast cancer.
Autorzy:
Chen W; School of Public Health, Fudan University, Shanghai, China. />Jiang Z
Shao Z
Sun Q
Shen K
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2009 Nov-Dec; Vol. 12 Suppl 3, pp. S82-4.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*economics
Breast Neoplasms/*drug therapy
Breast Neoplasms/*economics
Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/metabolism ; Chemotherapy, Adjuvant/economics ; China ; Cost-Benefit Analysis ; Female ; Humans ; Markov Chains ; Monte Carlo Method ; Quality-Adjusted Life Years ; Receptor, ErbB-2/metabolism ; Trastuzumab
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer.
Autorzy:
Garrison LP Jr; Department of Pharmacy,University of Washington, Health Sciences Building, Seattle, WA 98195-7630, USA. />Veenstra DL
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2009 Nov-Dec; Vol. 12 (8), pp. 1118-23. Date of Electronic Publication: 2009 Jul 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*economics
Breast Neoplasms/*drug therapy
Genes, erbB-2/*genetics
Adult ; Aged ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/economics ; Breast Neoplasms/genetics ; Cost-Benefit Analysis ; Decision Making ; Economics, Pharmaceutical ; Female ; Humans ; Middle Aged ; Models, Economic ; Prescription Drugs/economics ; Quality-Adjusted Life Years ; Trastuzumab ; United States ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial.
Autorzy:
Skedgel C; Department of Medicine, Dalhousie University, Halifax, NS, Canada.
Rayson D
Younis T
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2009 Jul-Aug; Vol. 12 (5), pp. 641-8.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents/*therapeutic use
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*drug effects
Antibodies, Monoclonal/economics ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/economics ; Breast Neoplasms/economics ; Cost-Benefit Analysis ; Drug Costs ; Female ; Humans ; Middle Aged ; Models, Theoretical ; Quality-Adjusted Life Years ; Risk ; Trastuzumab
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer.
Autorzy:
Reed SD; Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. />Schulman KA
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2009 Jul-Aug; Vol. 12 (5), pp. 637-40. Date of Electronic Publication: 2009 May 15.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents/*therapeutic use
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*drug effects
Antibodies, Monoclonal/economics ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/economics ; Breast Neoplasms/economics ; Cost-Benefit Analysis ; Drug Costs ; Economics, Pharmaceutical ; Female ; Humans ; Policy Making ; Trastuzumab
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom.
Autorzy:
Brown B; IMS Health, London, UK.
Diamantopoulos A
Bernier J
Schöffski P
Hieke K
Mantovani L
Launois R
Griebsch I
Robinson P
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2008 Sep-Oct; Vol. 11 (5), pp. 791-9. Date of Electronic Publication: 2008 Jan 11.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*economics
Head and Neck Neoplasms/*drug therapy
Head and Neck Neoplasms/*radiotherapy
Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/therapeutic use ; Belgium ; Cetuximab ; Confidence Intervals ; Cost-Benefit Analysis ; France ; Head and Neck Neoplasms/economics ; Head and Neck Neoplasms/mortality ; Humans ; Italy ; Models, Economic ; Radiotherapy/economics ; Survival Analysis ; Switzerland ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prevention of graft vs. host disease with alemtuzumab 'in the bag' decreases early toxicity of stem cell transplantation and in multiple myeloma is associated with improved long-term outcome.
Autorzy:
Novitzky N; Groote Schuur Hospital, Observatory, University of Cape Town Leukaemia Centre and Department of Haematology, Cape Town, South Africa. />Thomas V
du Toit C
Pokaż więcej
Źródło:
Cytotherapy [Cytotherapy] 2008; Vol. 10 (1), pp. 45-53.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antibodies, Neoplasm/*therapeutic use
Graft vs Host Disease/*prevention & control
Multiple Myeloma/*therapy
Stem Cell Transplantation/*methods
Adult ; Alemtuzumab ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal, Humanized ; Antibodies, Neoplasm/immunology ; Antigens, CD/immunology ; Antigens, Neoplasm/immunology ; CD52 Antigen ; Disease-Free Survival ; Glycoproteins/immunology ; Graft Survival ; Graft vs Host Disease/etiology ; Graft vs Host Disease/immunology ; Humans ; Lymphocyte Depletion ; Middle Aged ; Multiple Myeloma/immunology ; Stem Cell Transplantation/adverse effects ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Airway inflammation and eotaxin in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
Autorzy:
Zietkowski Z; Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. />Skiepko R
Tomasiak-Lozowska MM
Bodzenta-Lukaszyk A
Pokaż więcej
Źródło:
Advances in medical sciences [Adv Med Sci] 2011; Vol. 56 (2), pp. 318-22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Anti-Idiotypic/*pharmacology
Antibodies, Monoclonal, Humanized/*pharmacology
Chemokine CCL11/*metabolism
Immunoglobulin E/*immunology
Adult ; Anti-Allergic Agents/pharmacology ; Antibodies, Monoclonal/chemistry ; Eosinophils/metabolism ; Exhalation ; Female ; Humans ; Hypersensitivity/metabolism ; Immunoglobulin E/chemistry ; Inflammation/metabolism ; Male ; Middle Aged ; Nitric Oxide/metabolism ; Omalizumab ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Establishing risk of human experimentation with drugs: lessons from TGN1412.
Autorzy:
Kenter MJ; Central Committee on Research Involving Human Subjects, The Hague, Netherlands.
Cohen AF
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Oct 14; Vol. 368 (9544), pp. 1387-91.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Human Experimentation*
Risk Assessment*
Antibodies, Monoclonal/*adverse effects
Biotechnology/*trends
Clinical Trials as Topic/*methods
Amino Acid Sequence ; Animals ; Antibodies, Monoclonal/metabolism ; Antibodies, Monoclonal, Humanized ; Clinical Trials as Topic/ethics ; Humans ; Interleukins/biosynthesis ; Macaca mulatta ; Molecular Sequence Data
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 1894

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies